DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

PEG-Intron (Peginterferon Alfa-2B) - Depression - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Depression (79)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to PEG-Intron (Peginterferon Alfa-2B) where reactions include depression. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 79   Next >>

Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-24

Patient:

Reactions: Abdominal Pain, White Blood Cell Count Decreased, Confusional State, Tinnitus, Pain, Chills, Anaemia, Hot Flush, Fatigue, Diarrhoea, Depression, Decreased Appetite

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 ?g, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Ribasphere
    Dosage: unk
    Indication: Product Used FOR Unknown Indication
    Start date: 2012-04-27

Other drugs received by patient: Prograf



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-24

Patient:

Reactions: Fatigue, Insomnia, Depression, Influenza Like Illness

Drug(s) suspected as cause:
PEG-Intron
    Administration route: Oral

Ribasphere

Victrelis
    Dosage: 800 mg, q8h
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-01

Other drugs received by patient: Prozac; Ambien



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-24

Patient:

Reactions: Depression

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-06-11
    End date: 2012-07-06

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-11
    End date: 2012-07-12

Telavic
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-06-11
    End date: 2012-07-12

Other drugs received by patient: Gasmotin; Allegra; Nizatidine; Miltax PAP; Lexapro; Allopurinol; Mucosta; Urso 250; Allopurinol; Meilax; Loxonin; Rinderon V; Myser (Cycloserine); Zolpidem



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: White Blood Cell Count Decreased, Hepatitis C, Nausea, Anaemia, Rash, Headache, Dysgeusia, Irritability, Pruritus Generalised, Poor Quality Sleep, Malaise, Fatigue, Depression, Depressed Mood, Hypersomnia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 0.5 ml, unk
    Indication: Hepatitis C
    Start date: 2012-04-13

PEG-Intron
    Dosage: 0.4 ml, unk

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-08-23

Patient:

Reactions: Fatigue, Alopecia, Vision Blurred, Depression, Rash, Tremor

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Abdominal Pain, Intervertebral Disc Protrusion, Pain, Anaemia, Rash, Fall, Diverticulum Intestinal, Osteoarthritis, Colonic Polyp, Spinal Fusion Surgery, Fatigue, Iron Deficiency Anaemia, Dyspepsia, Depression, Leukopenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-01-18

Ribasphere
    Dosage: 600mg am and 400mg pm
    Start date: 2012-01-18

Telaprevir
    Dosage: unk
    Start date: 2012-02-01
    End date: 2012-01-01

Other drugs received by patient: Escitalopram Oxalate; Tizanidine Hydrochloride; Tylenol; Flector; Hydroxyzine Hydrochloride; Ibuprofen; Aleve; Flexeril; Omeprazole; Claritin



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-23

Patient:

Reactions: Inappropriate Schedule of Drug Administration, Bunion, Confusional State, Pain in Extremity, Adrenal Neoplasm, Varicose Vein, Fatigue, Insomnia, NO Therapeutic Response, Depression, Nervousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2006-01-06
    End date: 2006-06-23

PEG-Intron
    Dosage: unk
    Start date: 2012-07-06

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2006-01-06
    End date: 2006-06-23

Rebetol
    Dosage: unk
    Administration route: Oral
    Start date: 2012-07-06



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from Belgium on 2012-08-22

Patient:

Reactions: Pulmonary Embolism, Suicide Attempt, Depression, Deep Vein Thrombosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Blinded Boceprevir
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

PEG-Intron
    Dosage: 120 micrograms, qw
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-02-11
    End date: 2011-01-06

Peginterferon Alfa-2B
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Placebo
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Rebetol
    Dosage: 600 mg, bid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-02-11
    End date: 2011-01-07

Ribavirin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Simvastatin
    Dosage: 800 mg, tid
    Administration route: Oral
    Start date: 2010-03-11
    End date: 2011-01-07

Other drugs received by patient: Norvir; Zolpidem Tatrate; Reyataz; Xanax; Escitalopram Oxalate; Epivir; Imodium; Invirase



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-22

Patient:

Reactions: Malaise, Nausea, Anaemia, Insomnia, Depression, Rash, Constipation, Decreased Appetite

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-22

PEG-Intron
    Dosage: 1.0mcg/kg/week
    Start date: 2012-02-29
    End date: 2012-02-29

PEG-Intron
    Dosage: 0mcg/kg

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-14

Rebetol
    Administration route: Oral
    Start date: 2012-02-15
    End date: 2012-03-07

Rebetol
    Administration route: Oral

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-01
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-07

Telavic
    Administration route: Oral

Other drugs received by patient: [therapy Unspecified]; [therapy Unspecified]; Milmag; Senna-Mint WAF; [therapy Unspecified]



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from Japan on 2012-08-14

Patient:

Reactions: White Blood Cell Count Decreased, Depression

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-07-16

Rebetol
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2012-07-13
    End date: 2012-07-16

Rebetol
    Dosage: 800 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-08
    End date: 2012-07-12

Telavic
    Dosage: 1500 mg, qd
    Administration route: Oral

Telavic
    Dosage: 2250 mg, qd
    Indication: Hepatitis C



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-14

Patient:

Reactions: Malaise, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.3mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29

Telavic
    Administration route: Oral
    Start date: 2012-07-04

Telavic
    Administration route: Oral
    Start date: 2012-05-29
    End date: 2012-07-03

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-05-29

Other drugs received by patient: Olmesartan Medoxomil; Loxonin; Zolpidem; Rebamipide; Amlodipine



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-13

Patient:

Reactions: Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.3mcg/kg
    Start date: 2012-05-29

Rebetol
    Administration route: Oral
    Start date: 2012-05-29

Telavic
    Administration route: Oral
    Start date: 2012-05-29



Possible PEG-Intron side effects in

Reported by a physician from Japan on 2012-08-13

Patient:

Reactions: Renal Disorder, Anaemia, Depression, Hyperuricaemia

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 1.5mcg/kg/week
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-03-23

Rebetol
    Administration route: Oral
    Start date: 2012-02-29
    End date: 2012-03-25

Rebetol
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-21

Rebetol
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-02-28

Telavic
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-02-15
    End date: 2012-02-21

Telavic
    Administration route: Oral
    Start date: 2012-02-22
    End date: 2012-03-25

Other drugs received by patient: Urso 250; Gasmotin; Aspirin; Dogmatyl; Zaditen; Gasmotin; BIO Three; Hyalein; Diovan; Urso 250; Plavix; Famotidine; Pegasys; Loxonin; Amlodipine Besylate; Fucidine CAP; Amlodipine Besylate; Bisoprolol Fumarate; Mirtazapine; Diovan; Aspirin; Plavix; Bisoprolol Fumarate; Famotidine; Exforge; Exforge; Adofeed; Medicon (Dextromethorphan Hydrobromide); Hirudoid



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-08-10

Patient:

Reactions: Anaemia, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-13
    End date: 2012-01-01

Ribavirin
    Administration route: Oral
    Indication: Hepatitis C

Other drugs received by patient: Vitamins (Unspecified); Fluticasone Propionate; Fluticasone Propionate; Tramadol Hydrochloride; Pravastatin Sodium; Phenergan HCL; Hydrochlorothiazide; Simethicone; Synthroid; Alprazolam; Prozac; Aspirin; Bentyl; Mupirocin



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Confusional State, Hepatitis C, Pain, Aggression, Respiratory Tract Congestion, Biliary Drainage, Cholecystectomy, Memory Impairment, Depression, Fluid Retention

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2002-01-04
    End date: 2002-12-06

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2002-01-04
    End date: 2002-12-06



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-10

Patient:

Reactions: Pain, Polyuria, Headache, Pyrexia, Myalgia, Mood Altered, Neck Pain, Chest Pain, DRY Mouth, Breath Odour, Dizziness, Depression, Sinus Congestion, Nausea, Anaemia, Glucose Tolerance Impaired, Hypoaesthesia, Oropharyngeal Discomfort, Tremor, Mental Impairment, Sleep Disorder, Visual Impairment, Asthenia, Feeling Abnormal

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-03-09

Rebetol
    Dosage: 200 mg, unk
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-03-09

Telaprevir
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-03-09

Other drugs received by patient: Valium; Advil; Xanax; Ambien



Possible PEG-Intron side effects in

Reported by a individual with unspecified qualification from Japan on 2012-08-07

Patient:

Reactions: Renal Impairment, Anaemia, Depression

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
Antiviral (Unspecified)
    Dosage: 1500 mg, qd
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-04-01

Antiviral (Unspecified)
    Dosage: 2250 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-03-04

PEG-Intron
    Dosage: 80 microgram per week
    Start date: 2012-04-02
    End date: 2012-06-18

PEG-Intron
    Dosage: 1.5 microgram per week
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-02-27

PEG-Intron
    Dosage: 50 microgram week
    Start date: 2012-03-12
    End date: 2012-03-26

Peginterferon Alfa-2B
    Dosage: unk

Peginterferon Alfa-2B
    Dosage: 50 microgram per kilogram, qw
    Start date: 2012-03-12
    End date: 2012-03-26

Peginterferon Alfa-2B
    Dosage: 80 microgram per kilogram, qw
    Start date: 2012-04-02

Peginterferon Alfa-2B
    Dosage: 1.5 microgram per kilogram, qw
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-02-27

Rebetol
    Dosage: 600 mg, once
    Administration route: Oral
    Start date: 2012-04-02
    End date: 2012-05-13

Rebetol
    Dosage: 200 mg, qd
    Administration route: Oral
    Start date: 2012-02-27
    End date: 2012-03-02

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-02-26

Rebetol
    Dosage: 600 mg, qd
    Administration route: Oral
    Start date: 2012-04-02

Rebetol
    Dosage: 400 mg, once
    Administration route: Oral
    Start date: 2012-05-14
    End date: 2012-06-25

Telavic
    Dosage: 1500 mg, once
    Administration route: Oral
    Start date: 2012-03-05
    End date: 2012-04-01

Telavic
    Dosage: 2250 mg, once
    Administration route: Oral
    Indication: Hepatitis C
    Start date: 2012-01-10
    End date: 2012-03-04

Other drugs received by patient: Loxonin; [therapy Unspecified]; Lendormin D; Rabeprazole Sodium; Hirudoid; Locoid; Lendormin; Lendormin; [therapy Unspecified]; Xyzal; Petrolatum; Myser (Cycloserine); Electrolytes (Unspecified) (+) Sodium Lactate



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-06

Patient:

Reactions: Depression, Spinal Disorder, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-01-18

Ribasphere
    Dosage: unk
    Start date: 2012-01-18

Telaprevir
    Dosage: unk
    Start date: 2012-02-01
    End date: 2012-01-01



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient:

Reactions: Weight Decreased, Head Injury, Teeth Brittle, Loss of Consciousness, Malaise, Fatigue, Oral Candidiasis, Hyperchlorhydria, Depression, Decreased Appetite, Hypersomnia, Tooth Fracture, Dyspnoea, Vomiting, Anaemia, Rash, Dysgeusia, Anxiety, Alopecia, Insomnia, Hypophagia, Asthenia

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-10-25

Ribavirin
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-10-25

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2011-11-23



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-03

Patient:

Reactions: Fatigue, DRY Skin, Depression, Rash

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 80 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-05-01

Ribasphere

Other drugs received by patient: Lasix



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-08-01

Patient:

Reactions: Dyspnoea, Anaemia, Rash, Headache, Generalised Oedema, Anxiety, Gastrointestinal Pain, Fatigue, Diarrhoea, Visual Impairment, Depression, Mood Swings, Cough, Decreased Appetite

Adverse event resulted in: disablity

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27
    End date: 2012-07-16

Ribasphere
    Dosage: unk
    Start date: 2012-04-27
    End date: 2012-07-16

Telaprevir
    Dosage: unk



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-30

Patient:

Reactions: Bunion, Inappropriate Schedule of Drug Administration, Confusional State, Pain in Extremity, Adrenal Neoplasm, Varicose Vein, Fatigue, NO Therapeutic Response, Insomnia, Depression, Nervousness

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2006-01-06
    End date: 2006-06-23

PEG-Intron
    Dosage: unk
    Start date: 2012-07-06

Rebetol
    Dosage: unk
    Administration route: Oral
    Start date: 2012-07-06

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2006-01-06
    End date: 2006-06-23



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-28

Patient:

Reactions: Agitation, Abdominal Pain, Chills, Blood Count Abnormal, Hyperhidrosis, Suicidal Ideation, Fatigue, Dyspepsia, Anger, Depression, Mood Swings, Dysphagia, Nausea, Irritability, Flank Pain, Influenza Like Illness

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-05-26

Rebetol
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-01-24
    End date: 2012-05-26

Victrelis
    Dosage: unk unk, unknown
    Indication: Hepatitis C
    Start date: 2012-02-21
    End date: 2012-05-26

Other drugs received by patient: Lexapro; Prozac



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25

Patient:

Reactions: Weight Decreased, Rash Generalised, Nausea, Anaemia, Pain, Fatigue, Arthralgia, Alopecia, Vision Blurred, Depression, Temperature Intolerance

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-03-01

Ribasphere

Victrelis
    Administration route: Oral

Other drugs received by patient: Cyanocobalamin; Vitamin E; Pyridoxine HCL; Ascorbic Acid; Flaxseed



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-25

Patient:

Reactions: Vomiting, Rash Generalised, Dyspnoea, Nausea, Anaemia, Headache, Generalised Oedema, Anxiety, Fatigue, Diarrhoea, Mood Swings, Depression, Blindness, Muscle Spasms, Decreased Appetite, Cough

Adverse event resulted in: hospitalization

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 150 microgram, qw
    Indication: Hepatitis C
    Start date: 2012-04-27

Ribasphere
    Dosage: unk
    Start date: 2012-04-27

Telaprevir



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-23

Patient:

Reactions: White Blood Cell Count Decreased, Nausea, Anaemia, Rash, Headache, Irritability, Dysgeusia, Fatigue, Malaise, Depression, Depressed Mood

Drug(s) suspected as cause:
PEG-Intron
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Rebetol
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-04-13

Victrelis
    Dosage: unk
    Indication: Hepatitis C
    Start date: 2012-05-11



Possible PEG-Intron side effects in

Reported by a consumer/non-health professional from United States on 2012-07-20

Patient:

Reactions: Homicide, Haematocrit Decreased, Depression

Drug(s) suspected as cause:
PEG-Intron



Possible PEG-Intron side effects in

Reported by a health professional (non-physician/pharmacist) from United States on 2012-07-19

Patient:

Reactions: Depression, Depressed Mood

Drug(s) suspected as cause:
PEG-Intron
    Dosage: 120 mg, qw
    Indication: Hepatitis C
    Start date: 2010-10-20

Rebetol



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-18

Patient:

Reactions: Depression

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Avastin



Possible PEG-Intron side effects in

Reported by a physician from United States on 2012-07-14

Patient:

Reactions: Depression, Decreased Interest

Drug(s) suspected as cause:
PEG-Intron

Other drugs received by patient: Ribavirin



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2014